臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"tseng l h"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 86-110 / 253 (共11頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2020-06-19T02:38:41Z	Human T-lymphotropic virus type II infection in Vietnamese thalassemic patients	Lin M.T.;Nguyen B.T.;Binh T.V.;Be T.V.;Chiang T.Y.;Tseng L.H.;Ya-Chien Yang;Lin K.H.;Chen Y.C.; Lin M.T.; Nguyen B.T.; Binh T.V.; Be T.V.; Chiang T.Y.; Tseng L.H.; YA-CHIEN YANG; Lin K.H.; Chen Y.C.
臺大學術典藏	2020-06-19T02:38:41Z	Subtyping of human T-lymphotropic virus type I by amplification of long terminal repeat sequences and restriction fragment length polymorphism analysis in carriers with multiple transfusions	Lin M.-T.;Ya-Chien Yang;Chen P.-J.;Tang J.-L.;Tseng L.-H.;Wang C.-W.;Chen Y.-C.; Lin M.-T.; YA-CHIEN YANG; Chen P.-J.; Tang J.-L.; Tseng L.-H.; Wang C.-W.; Chen Y.-C.
臺大學術典藏	2020-06-19T02:38:40Z	Familial transmission of human T-lymphocyte virus type (HTLV-1) in patients with adult T-cell leukemia/lymphoma or HTLV-1-associated myelopathy	Yang C.-S.;Chen Y.-C.;Wang C.-H.;Tseng L.-H.;Tang J.-L.;YA-CHIEN YANG;Lin M.-T.;Hu C.-Y.; Hu C.-Y.; Lin M.-T.; YA-CHIEN YANG; Tang J.-L.; Tseng L.-H.; Wang C.-H.; Chen Y.-C.; Yang C.-S.
臺大學術典藏	2020-06-16T07:53:31Z	Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations	Liang Y.-H.;Lin Y.-L.;Liau J.-Y.;Tsai J.-H.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Tseng L.-H.;Liang-In Lin;Chang Y.-L.;Cheng A.-L.;Yeh K.-H.; Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Tseng L.-H.; LIANG-IN LIN; Chang Y.-L.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏	2020-06-16T07:53:29Z	Frequent BRAF mutation in early-onset colorectal cancer in Taiwan: Association with distinct clinicopathological and molecular features and poor clinical outcome	Tsai J.-H.;Liau J.-Y.;Lin Y.-L.;Tseng L.-H.;Liang-In Lin;Yeh K.-H.;Jeng Y.-M.; Tsai J.-H.; Liau J.-Y.; Lin Y.-L.; Tseng L.-H.; LIANG-IN LIN; Yeh K.-H.; Jeng Y.-M.
臺大學術典藏	2020-06-16T07:53:23Z	CpG Island Methylator Phenotype May Predict Poor Overall Survival of Patients with Stage IV Colorectal Cancer	Chen K.-H.;Liang-In Lin;Tseng L.-H.;Lin Y.-L.;Liau J.-Y.;Tsai J.-H.;Liang J.-T.;Lin B.-R.;Cheng A.-L.;Yeh K.-H.; Chen K.-H.; LIANG-IN LIN; Tseng L.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏	2020-04-24T01:34:13Z	Prediction Model for Audiological Outcomes in Patients With GJB2 Mutations	Hsu C.-J.; Chen-Chi Wu; Chen P.-Y.; Lin Y.-H.; Liu T.-C.; Lin Y.-H.; Tseng L.-H.; Yang T.-H.; Chen P.-L.
臺大學術典藏	2020-03-09T09:11:13Z	Prediction Model for Audiological Outcomes in Patients With GJB2 Mutations	Chen P.-Y.; Lin Y.-H.; TIEN-CHEN LIU; Lin Y.-H.; Tseng L.-H.; Yang T.-H.; Chen P.-L.; Wu C.-C.; Hsu C.-J.
臺大學術典藏	2020-03-07T06:56:33Z	Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer	YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L.; Lin Y.-L.; Liau J.-Y.; Yu S.-C.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.
臺大學術典藏	2020-03-07T06:56:33Z	KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer Cells	Lin Y.-L.; Liau J.-Y.; Yu S.-C.; Ou D.-L.; Lin L.-I.; Tseng L.-H.; YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L.
臺大學術典藏	2020-03-07T06:56:25Z	Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients	YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L.; Tseng L.-H.; Lin L.-I.; Hung J.-S.; Lin B.-R.; Liau J.-Y.; Liang J.-T.; Tsai J.-H.; Liang Y.-H.; Lin Y.-.; Lin Y.-.;Liang Y.-H.;Tsai J.-H.;Liau J.-Y.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Lin L.-I.;Tseng L.-H.;Yih-Leong Chang;Yeh K.-H.;Cheng A.-L.
臺大學術典藏	2020-03-07T06:56:23Z	Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations	Liang Y.-H.;Lin Y.-L.;Liau J.-Y.;Tsai J.-H.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Tseng L.-H.;Lin L.-I.;Yih-Leong Chang;Cheng A.-L.;Yeh K.-H.; Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Tseng L.-H.; Lin L.-I.; YIH-LEONG CHANG; Cheng A.-L.; Yeh K.-H.
臺大學術典藏	2020-03-07T06:56:18Z	BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer	Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L.; Chen K.-H.;Lin Y.-L.;Liau J.-Y.;Tsai J.-H.;Tseng L.-H.;Lin L.-I.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Yih-Leong Chang;Yeh K.-H.;Cheng A.-L.; Chen K.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.
臺大學術典藏	2020-03-07T06:42:09Z	Ovarian and endometrial endometrioid adenocarcinomas have distinct profiles of microsatellite instability, PTEN expression, and ARID1A expression	Huang H.-N.;Lin M.-C.;Tseng L.-H.;Chiang Y.-C.;Lin L.-I.;Lin Y.-F.;Huang H.-Y.;Kuan-Ting Kuo; Huang H.-Y.; KUAN-TING KUO; Lin L.-I.; Lin Y.-F.; Chiang Y.-C.; Tseng L.-H.; Lin M.-C.; Huang H.-N.
臺大學術典藏	2020-03-07T06:42:08Z	Immunohistochemical study of endometrial high-grade endometrioid carcinoma with or without a concurrent low-grade component: Implications for pathogenetic and survival differences	Mao T.-L.;Ayhan A.;Kuan-Ting Kuo;Lin M.-C.;Tseng L.-H.;Ogawa H.; Mao T.-L.; Ayhan A.; KUAN-TING KUO; Lin M.-C.; Tseng L.-H.; Ogawa H.
臺大學術典藏	2020-03-07T06:42:06Z	Epithelioid Trophoblastic Tumor Around an Abdominal Cesarean Scar: A Pathologic and Molecular Genetic Analysis	Hsiue E.H.-C.;Hsu C.;Tseng L.-H.;Lu T.-P.;Kuan-Ting Kuo; Hsiue E.H.-C.; Hsu C.; Tseng L.-H.; Lu T.-P.; KUAN-TING KUO
臺大學術典藏	2020-03-06T08:25:01Z	Aberrant expression of annexin A10 is closely related to gastric phenotype in serrated pathway to colorectal carcinoma	Tsai J.-H.;Lin Y.-L.;Cheng Y.-C.;Chen C.-C.;Lin L.-I.;Tseng L.-H.;Cheng M.-L.;Liau J.-Y.;Yung-Ming Jeng; Tsai J.-H.; Lin Y.-L.; Cheng Y.-C.; Chen C.-C.; Lin L.-I.; Tseng L.-H.; Cheng M.-L.; Liau J.-Y.; YUNG-MING JENG
臺大學術典藏	2020-03-06T08:24:56Z	RNF43 is an early and specific mutated gene in the serrated pathway, with increased frequency in traditional serrated adenoma and its associated malignancy	Tsai J.-H.; Liau J.-Y.; Yuan C.-T.; Lin Y.-L.; Tseng L.-H.; Cheng M.-L.; YUNG-MING JENG
臺大學術典藏	2020-03-06T08:24:55Z	Frequent BRAF mutation in early-onset colorectal cancer in Taiwan: Association with distinct clinicopathological and molecular features and poor clinical outcome	Tsai J.-H.;Liau J.-Y.;Lin Y.-L.;Tseng L.-H.;Lin L.-I.;Yeh K.-H.;Yung-Ming Jeng; Tsai J.-H.; Liau J.-Y.; Lin Y.-L.; Tseng L.-H.; Lin L.-I.; Yeh K.-H.; YUNG-MING JENG
臺大學術典藏	2020-03-06T05:26:20Z	Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer	Lin Y.-L.; Liau J.-Y.; Yu S.-C.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L.
臺大學術典藏	2020-03-06T05:26:15Z	Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients	Lin Y.-.; Liang Y.-H.; Tsai J.-H.; Liau J.-Y.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Lin L.-I.; Tseng L.-H.; YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L.
臺大學術典藏	2020-03-06T05:26:12Z	Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations	Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Tseng L.-H.; Lin L.-I.; YIH-LEONG CHANG; Cheng A.-L.; Yeh K.-H.
臺大學術典藏	2020-03-06T05:26:09Z	BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer	Chen K.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L.
臺大學術典藏	2020-03-05T12:32:49Z	Immunohistochemical study of endometrial high-grade endometrioid carcinoma with or without a concurrent low-grade component: Implications for pathogenetic and survival differences	TSUI-LIEN MAO; Ayhan A.; Kuo K.-T.; Lin M.-C.; Tseng L.-H.; Ogawa H.
臺大學術典藏	2020-03-05T12:22:25Z	Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer	Lin Y.-L.; Liau J.-Y.; SHAN-CHI YU; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.

顯示項目 86-110 / 253 (共11頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :2851816
	造訪人次 : 44926208 線上人數 : 1652 教育部委託研究計畫計畫執行:國立臺灣大學圖書館